Bulletin 2010/15 - European Patent Office
22.12.2012 • Views
Share Embed Flag

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) I.1(1)<br />

(25) En (26) En<br />

(21) 07848670.1 (22) 21.12.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(86) GB 2007/004947 21.12.2007<br />

(87) WO 2008/078095 2008/27 03.07.2008<br />

(30) 22.12.2006 GB 0625844<br />

(54) • BEHANDLUNG VON MAKULADEGENERA-<br />

TION<br />

• TREATMENT OF MACULAR DEGENERA-<br />

TION<br />

• TRAITEMENT DE LA DÉGÉNÉRESCENCE<br />

MACULAIRE<br />

(71) Summit (Cambridge) Ltd., 7340 Cambridge<br />

Research Park Beach Drive Waterbeach,<br />

Cambridge CB25 9TN, GB<br />

(72) RICHARDS, Frances, Margaret, Oxfordshire<br />

OX14 4RY, GB<br />

ROACH, Alan, George, Oxfordshire OX14<br />

4RY, GB<br />

(74) Perry, Robert Edward, Gill Jennings & Every<br />

LLP Broadgate House 7 Eldon Street,<br />

London EC2M 7LH, GB<br />

A61K 31/00 → (51) A61K 31/407<br />

(51) A61K 31/05 (11) 2 173 332 A1*<br />

A61K 31/352 A61K 36/185<br />

A61P 3/04 A61P 19/08<br />

A61P 25/00<br />

(25) En (26) En<br />

(21) 08775863.7 (22) 04.07.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) GB 2008/0023<strong>15</strong> 04.07.2008<br />

(87) WO 2009/007697 2009/03 <strong>15</strong>.01.2009<br />

(30) 06.07.2007 GB 0713175<br />

(54) • NEUE PHARMAZEUTISCHE FORMULIE-<br />

RUNG MIT CANNABIDIOL UND TETRA-<br />

HYDROCANNABIDIVARIN<br />

• NEW PHARMACEUTICAL FORMULATION<br />

COMPRISING CANNABIDIOL AND TETRA-<br />

HYDROCANNABIDIVARIN<br />

• NOUVELLE PRÉPARATION PHARMACEU-<br />

TIQUE COMPRENANT DU CANNABIDIOL<br />

ET DE LA TÉTRAHYDROCANNABIDIVA-<br />

RINE<br />

(71) GW Pharma Limited, Porton Down Science<br />

Park, Salisbury Wiltshire SP4 OJQ, GB<br />

(72) GUY, Geoffrey, Salisbury Wiltshire SP4 OJQ,<br />

GB<br />

WHITTLE, Brian, Salisbury Wiltshire SP4<br />

OJQ, GB<br />

PERTWEE, Roger, Aberdeen Scotland AB25<br />

2ZD, GB<br />

(74) Harrison Goddard Foote, 4th Floor Merchant<br />

Exchange 17-19 Whitworth Street West,<br />

Manchester M1 5WG, GB<br />

A61K 31/12 → (51) C07C 49/84<br />

A61K 31/13 → (51) A61K 31/45<strong>15</strong><br />

(51) A61K 31/131 (11) 2 173 333 A2*<br />

A61K 31/519 A61P 35/00<br />

(25) En (26) En<br />

(21) 07865990.1 (22) 21.12.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 2007/088666 21.12.2007<br />

(87) WO 2008/083107 2008/28 10.07.2008<br />

(88) 21.01.<strong>2010</strong><br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(30) 29.12.2006 US 877836 P<br />

03.01.2007 US 883266 P<br />

08.01.2007 US 883959 P<br />

(54) • ANTIFOLATKOMBINATIONEN ZUR<br />

KREBSBEHANDLUNG<br />

• COMBINATIONS OF ANTIFOLATE AGENT<br />

AND METHOXYAMINE IN THE TREAT-<br />

MENT OF CANCER<br />

• COMBINAISONS D'AGENTS ANTIFOLI-<br />

QUES UTILISÉES DANS LE TRAITEMENT<br />

DU CANCER<br />

(71) Tracon Pharmaceuticals, Inc., 4510 Executive<br />

Drive Suite 330, San Diego, CA 92121,<br />

US<br />

(72) THEUER, Charles, P., Carlsbad, CA 92009,<br />

US<br />

ADAMS, Bonne, Jean, San Diego, CA 92110,<br />

US<br />

(74) Sahans, Sarah Anne, et al, HLBBshaw Merlin<br />

House Falconry Court Baker's Lane, Epping,<br />

Essex CM16 5DQ, GB<br />

A61K 31/135 → (51) A61K 31/138<br />

A61K 31/135 → (51) C07D 211/42<br />

A61K 31/136 → (51) A61K 31/517<br />

A61K 31/137 → (51) A61K 9/50<br />

(51) A61K 31/138 (11) 2 173 334 A1*<br />

A61K 31/<strong>15</strong> A61K 31/4525<br />

A61K 31/135 A61K 31/343<br />

A61P 27/02<br />

(25) En (26) En<br />

(21) 08775517.9 (22) 27.06.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) FI 2008/050392 27.06.2008<br />

(87) WO 2009/004114 2009/02 08.01.2009<br />

(30) 29.06.2007 FI 20075498<br />

(54) • VERFAHREN ZUR BEHANDLUNG VON<br />

AMBLYOPIE<br />

• A METHOD OF TREATING AMBLYOPIA<br />

• PROCÉDÉ DE TRAITEMENT D'UNE<br />

AMBLYOPIE<br />

(71) Hermo Pharma Oy, Viikinkaari 4, 00790<br />

Helsinki, FI<br />

(72) CASTRÉN, Eero, FI-00014 Helsinki, FI<br />

MAFFEI, Lamberto, I-56100 Pisa, IT<br />

MAYA VETENCOURT, Jose, I-56100 Pisa, IT<br />

(74) Matilainen, Mirja Helena, et al, Oy Jalo Ant-<br />

Wuorinen AB, Iso Roobertinkatu 4-6 A,<br />

00120 Helsinki, FI<br />

A61K 31/<strong>15</strong> → (51) A61K 31/138<br />

A61K 31/16 → (51) C07C 323/32<br />

A61K 31/165 → (51) A61K 31/45<strong>15</strong><br />

A61K 31/167 → (51) A61K 31/53<br />

(51) A61K 31/18 (11) 2 173 335 A2*<br />

A61P <strong>15</strong>/06 A61P <strong>15</strong>/00<br />

(25) En (26) En<br />

(21) 08827<strong>15</strong>7.2 (22) 04.07.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) IB 2008/002752 04.07.2008<br />

(87) WO 2009/019607 2009/07 12.02.2009<br />

(88) 09.04.2009<br />

(30) 05.07.2007 EP 07290845<br />

41<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>15</strong>/<strong>2010</strong>) 14.04.<strong>2010</strong><br />

(54) • DERIVATE VON BETA-ADRENERGISCHEN<br />

REZEPTOR-LIGANDEN ZUR APOPTOSE-<br />

MODULATION<br />

• BETA ADRENERGIC RECEPTOR LIGAND<br />

DERIVATIVES FOR MODULATING APOP-<br />

TOSIS<br />

• DÉRIVÉS D'UN LIGAND À RÉCEPTEUR<br />

ADRÉNERGIQUE BÊTA POUR MODULER<br />

L'APOPTOSIS<br />

(71) Sanofi-Aventis, 174 Avenue de France,<br />

75013 Paris, FR<br />

(72) The designation of the inventor has not yet<br />

been filed<br />

(74) Rauline, Mathilde, Sanofi-Aventis Département<br />

Brevets 174 Avenue de France, 75013<br />

Paris, FR<br />

(51) A61K 31/194 (11) 2 173 336 A1*<br />

A61K 31/198 A61P 9/14<br />

(25) En (26) En<br />

(21) 08767263.0 (22) 27.06.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) SE 2008/050797 27.06.2008<br />

(87) WO 2009/005464 2009/02 08.01.2009<br />

(30) 02.07.2007 SE 0701602<br />

(54) • NEUE VERWENDUNG VON BEKANNTEN<br />

PHARMAKOLOGISCH WIRKSAMEN CHE-<br />

MISCHEN VERBINDUNGEN<br />

• NEW USE OF KNOWN PHARMACOLOGI-<br />

CALLY ACTIVE CHEMICAL COMPOUNDS<br />

• NOUVELLE UTILISATION DE COMPOSÉS<br />

CHIMIQUES PHARMACOLOGIQUEMENT<br />

ACTIFS CONNUS<br />

(71) Entress AB, Sveavägen 17, 14 Tr, 111 57<br />

Stockholm, SE<br />

(72) PIERZYNOWSKI, Stefan, G., S-211 14<br />

Malmö, SE<br />

(74) Aurell, Henrik, Albihns AB Studentgatan 4<br />

Box 4289, 203 14 Malmö, SE<br />

A61K 31/195 → (51) A01N 37/44<br />

A61K 31/198 → (51) A61K 9/06<br />

A61K 31/198 → (51) A61K 31/194<br />

A61K 31/201 → (51) A61K 35/20<br />

(51) A61K 31/282 (11) 2 173 337 A2*<br />

A61K 33/24<br />

(25) En (26) En<br />

(21) 08797320.2 (22) 06.08.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) US 2008/072398 06.08.2008<br />

(87) WO 2009/021082 2009/07 12.02.2009<br />

(88) 23.04.2009<br />

(30) 06.08.2007 US 954126 P<br />

20.09.2007 US 973926 P<br />

(54) • PHOSPHAPLATINE UND IHRE VERWEN-<br />

DUNG BEI DER BEHANDLUNG VON<br />

GEGEN CISPLANTIN UND CARBOPLATIN<br />

RESISTENTEN KREBSERKRANKUNGEN<br />

• PHOSPHAPLATINS AND THEIR USE IN<br />

THE TREATMENT OF CANCERS RESIS-<br />

TANT TO CISPLANTIN AND CARBOPLATIN<br />

• PHOSPHOPLATINES ET LEUR UTILISA-<br />

TION DANS LE TRAITEMENT DE CANCERS<br />

RÉSISTANT AU CISPLATINE ET CARBO-<br />

PLATINE<br />

(71) OHIO UNIVERSITY, Technology Transfer<br />

<strong>Office</strong> Unit 14 340 West State Street, Athens,<br />

Ohio 45701, US

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!